BIIB

BIIB Net Receivables

$1.89BQuarterly · USD

Period ending:

BIIB FY Net ReceivablesUSD
BIIB FY Net Receivables1985-12-31: $2.20M1986-12-31: $1.70M1987-12-31: $2.70M1988-12-31: $1.60M1989-12-31: $5.80M1990-12-31: $13.20M1991-12-31: $18.40M1992-12-31: $33.40M1993-12-31: $31.70M1994-12-31: $18.50M1995-12-31: $19.61M1996-12-31: $42.95M1997-12-31: $86.80M1998-12-31: $101.28M1999-12-31: $137.36M2000-12-31: $143.18M2001-12-31: $177.58M2002-12-31: $105.21M2003-12-31: $198.52M2004-12-31: $450.49M2005-12-31: $468.05M2006-12-31: $539.36M2007-12-31: $595.73M2008-12-31: $667.09M2009-12-31: $760.90M2010-12-31: $839.99M2011-12-31: $831.23M2012-12-31: $955.24M2013-12-31: $1.08B2014-12-31: $1.58B2015-12-31: $1.54B2016-12-31: $1.74B2017-12-31: $2.32B2018-12-31: $2.49B2019-12-31: $2.47B2020-12-31: $2.33B2021-12-31: $1.96B2022-12-31: $2.14B2023-12-31: $2.10B2024-12-31: $1.87B2025-12-31: $1.87B$2.49B$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BIIB net receivables history

Net amount expected from customer receivables. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Biogen Net Receivables — Annual fiscal periods (USD)
Period endingNet Receivables (USD)
1,867,000,000
1,868,800,000
2,100,000,000
2,136,400,000
1,961,700,000
2,327,300,000
2,470,700,000
2,485,400,000
2,319,600,000
1,742,200,000
1,541,500,000
1,575,805,000
1,077,068,000
955,243,000
831,227,000
839,988,000
760,897,000
667,090,000
595,732,000
539,355,000
468,048,000
450,488,000
198,524,000
105,208,000
177,582,000
143,178,000
137,363,000
101,281,000
86,802,000
42,952,000
19,612,000
18,502,000
31,700,000
33,400,000
18,400,000
13,200,000
5,800,000
1,600,000
2,700,000
1,700,000
2,200,000

Compare net receivables

All BIIB financial metrics · BIIB stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.